Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001415889-25-010164
Filing Date
2025-04-04
Accepted
2025-04-04 14:12:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 10461
  Complete submission text file 0001415889-25-010164.txt   12123
Mailing Address 220 E FIRST ST BETHLEHEM PA 18015
Business Address 220 E FIRST ST BETHLEHEM PA 18015 5036416115
ORASURE TECHNOLOGIES INC (Subject) CIK: 0001116463 (see all company filings)

EIN.: 364370966 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-59673 | Film No.: 25813042
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1290 AVENUE OF THE AMERICAS NEW YORK NY 10104
Business Address 1290 AVENUE OF THE AMERICAS NEW YORK NY 10104 212-476-9000
Neuberger Berman Group LLC (Filed by) CIK: 0001465109 (see all company filings)

EIN.: 611591182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G